Skip to navigation
Skip to content
Search:
Home
Technology
Science
Environment
Culture
News Briefs
Teva’s Generic EpiPen Gets Green Light For US Market
The Israel-based company's generic alternative for US sufferers of anaphylaxis comes two years after Mylan raised the price of its branded drug EpiPen to $600.
News Briefs
August 20, 2018
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Reset
Reset
Thank You for 14 Wonderful Years!
We’re pausing new activities but invite you to explore our archive of articles on Israeli innovation. Thank you for being part of our journey!
